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Caryocar brasiliense Camb. “pequi” is a native plant from the Cerrado region of Brazil that contains bioactive components reported
to be antioxidant agents. Previous work has demonstrated that dietary supplementation with pequi decreased the arterial pressure
of volunteer athletes. We found that the crude hydroalcoholic extract (CHE) of C. brasiliense leaves relaxed, in a concentration-
dependent manner, rat aortic rings precontracted with phenylephrine, and that the butanolic fraction (BF) produced an eﬀect
similar to that of the CHE. Aortic relaxation induced by BFwas abolished by endothelium removal, by incubation of the nitric oxide
synthase inhibitor L-NAME, or the soluble guanylatecyclase inhibitor ODQ. However, incubation with atropine and pyrilamine
had no eﬀect on the BF-induced vasorelaxation.Moreover, this eﬀect was not inhibited by indomethacin and tetraethylammonium.
The concentration-response curve to calcium in denuded-endothelium rings was not modified after incubation with BF, and
the vasorelaxation by BF in endothelium-intact rings precontracted with KCl was abolished after incubation with L-NAME.
In addition, administration of BF in anesthetized rats resulted in a reversible hypotension. The results reveal that C. brasiliense
possesses both in vivo and in vitro activities and that the vascular eﬀect of BF involves stimulation of the nitric oxide/cyclic GMP
pathway.
1. Introduction
Caryocar brasiliense Camb., known as “pequi,” is a tree that
belongs to the Caryocaraceae family and is widely distributed
in the Cerrado region of Brazil [1, 2]. Pequi fruit are rich in A
and E vitamins [3] and are popularly used to flavor cuisine.
Oil extracted from the fruits is used in the cosmetic industry
for the production of soaps and skin creams and is a useful
tool in the production of fuel and lubricants [4, 5]. In folk
medicine, pequi fruit is used against colds and flu. The seed
fat is used for the treatment of respiratory tract diseases, such
as asthma and bronchitis, whereas a decoction of the leaves
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and flowers is used to boost energy, as an aphrodisiac, and
for the treatment of liver disease. The bark and fruit are used
as febrifuges and diuretics [3].
Studies exploring the biological eﬀects of C. brasiliense
have shown that the hydroethanolic extract of pequi leaves
presents leishmanicidal, antibacterial, and antioxidant eﬀects
[6]. In addition, the aqueous extract of pequi fruit pulp has
revealed anticlastogenic potential, antigenotoxic activity, and
antioxidant properties [7, 8].
The chemical characterization of polar components of
pequi ethanolic extracts revealed the presence of bioactive
components widely reported as antioxidant agents, including
gallic acid, quinic acid, quercetin, and quercetin 3-O-
arabinose [9]. Several studies suggest that increased intake of
antioxidant compounds may help to protect against chronic
pathologies, such as cardiovascular diseases [10–14], and a
recent study has shown that dietary supplementation with
pequi decreased the arterial pressure of volunteer athletes
when compared to a control group [15].
The aim of the present study was to evaluate the
vasorelaxant eﬀect of the crude hydroalcoholic extract (CHE)
from C. brasiliense leaves in rat thoracic aorta, to determine
the active organic fractions of CHE, and to investigate the
mechanisms of action. In addition, we analyzed the in vivo
eﬀect of the extract of the active organic fraction.
2. Material andMethods
2.1. Chemicals, Reagents, and Standards. Phenylephrine
(Phe), acetylcholine (ACh), sodium nitroprusside (SNP),
Nω-nitro-L-arginine methyl ester (L-NAME), tetraethylam-
monium (TEA), indomethacin, 1H-[1, 2, 4]oxadiazolo[4,3-
alpha]quinoxalin-1-one (ODQ), atropine, pyrilamine, stan-
dards of gallic acid (97.5–102.5%), and quercetin (≥98%)
were purchased from Sigma-Aldrich Co. (St. Louis, MO,
USA). Methanol, acetonitrile (HPLC grade), and formic
acid (88%) were purchased from J. T. Baker Chemicals B.
V. (Deventer, The Netherlands), and ammonium formate
was purchased from Acros Organics (New Jersey, USA).
Ultrapure water was obtained using a Milli-Q purification
system from Millipore (Bedford, MA, USA).
2.2. Plant Material. Leaves of C. brasiliense Camb. were
collected on September 2010 in Gurupi, Tocantins, Brazil.
The plant was authenticated by Proﬀessor Aristoˆnio Mag-
alha˜es Teles, and a voucher specimen was deposited at the
herbarium of the Institute of Biological Sciences of the
Federal University of Goia´s under number 1353. The leaves
were maintained at room temperature (35◦C) for drying and
stabilization. The plant material was pulverized in a Willye
mill.
2.3. Crude Hydroalcoholic Extract Preparation. To prepare
the crude hydroalcoholic extract (CHE) of C. brasiliense
leaves, 50 g of powdered leaves were immersed in 1000mL
of an ethanol-water solution (70 : 30, v/v), for 48–72 h, with
occasional stirring. The extract was then vacuum-filtered,
concentrated in a rotary evaporator at reduced pressure and
at a temperature lower than 50◦C, lyophilized and stored in
the dark at 4◦C.
2.4. Crude Hydroalcoholic Extract Fractionation. The CHE
(10 g) was dissolved in water (500mL) and extracted with n-
hexane (3× 300mL) at room temperature. After the removal
of the hexane fraction, the remaining aqueous extract was
eluated with chloroform (3 × 300mL). After the removal
of the chloroform fraction, the remaining aqueous extract
was eluated with ethyl acetate (3 × 300mL). After removal
of the ethyl acetate fraction, the remaining aqueous layer
was extracted with n-butanol (3 × 300mL). Then, after
the removal of the n-butanol fraction, each of the fractions
(except the final aqueous portion) was separately evaporated
to dryness under reduced pressure to give a hexane fraction
(HF) (0.29 g), a chloroform fraction (CF) (0.37 g), an ethyl
acetate fraction (EAF) (1.76 g), and an n-butanol fraction
(BF) (1.37 g). The final aqueous layer was disposed of.
2.5. Standards and BF Preparation for LC-MS Analysis.
Stock solutions of gallic acid and quercetin standards
were prepared separately in methanol at concentrations
of 1mg/mL. All stock solutions were stored under refrig-
eration at 4◦C. Working solutions were obtained from
stock solutions by appropriate dilution in methanol/water
solution (70 : 30 v/v) containing 1% formic acid or 1mM
ammonium formate, depended of each experiment, to the
final concentration of 0.5 μg/mL, 50 μg/mL and 2mg/mL
of gallic acid, and quercetin and BF solutions, respectively.
All working standard solutions and samples were filtered
through a polyvinylidene fluoride (PVDF) syringe filter
(11mm, 0.45mm, Millipore Millex, Billerica, MA, USA)
before injection into the LC-MS system.
2.6. LC-MS Instrumentation and Conditions. LC-ESIMS
analyses were performed using an Agilent 1200 RR-HT
System (Wilmington, NC, USA) that consisted of a G1311A
binary pump, G1379A degasser, and G1316A column
oven. These were connected with a CTC Sample Manager
(Model 2777, Waters, Milford, CT, USA). The system was
coupled to an Applied Biosystems MDS Sciex API 3200
Triple Quadrupole Mass Spectrometer (Toronto, Canada)
equipped with a syringe pump Harvard 22 Dual Model
(Harvard Apparatus, South Natick, MA, USA) and an
Electrospray ionization (ESI) source. The ESI source was
operated in the positive and negative ion mode for monitor-
ing quercetin and in the negative ion mode. For monitoring
gallic acid in the butanolic fraction. For the positive ion
mode, the mobile phase consisted of methanol/water solu-
tion (10 : 90 v/v) (A) and acetonitrile (B), both containing
1% formic acid. The flow rate was maintained at 300 μL/min,
and the gradient profile was as follows: t0–5.0 min: A = 100%
to 90%; t5.0–35.0 min: A = 90% to 30%; t35.0–40.0 min: A =
30%; t40.0–41.0 min: A = 30% to 100%; t41.0–46.0 min: A = 100%.
For the negative ion mode, the mobile phase consisted of
methanol/water solution (10 : 90 v/v) (A) and acetonitrile (B)
both containing 1mM ammonium formate. The flow rate
and the gradient profile were the same used for the positive
ion mode. For both methods, the analyte separations were
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achieved on an XBridge C18 150 × 2.1mm (5mm particle
size) column coupled with an XBridge C18 10 × 2.1mm
(5mm particle size) guard column. The injection volume
was 20 μL, and the column temperature was maintained
at 25◦C. Data acquisition was performed with the MS
Workstation by Analyst 1.4 software (ABI/Sciex). The MS
and ion-source parameters for ESI-positive mode were the
following: declustering potential (DP), 40; entrance potential
(EP), 10; curtain gas (CUR), 10 psi; ion spray voltage (IS),
5500V; nebulizer gas (GS1), 45 psi; turbo gas (GS2), 45 psi;
temperature, 400◦C. The MS and ion source parameters for
ESI negative mode were as follows: declustering potential
(DP), −40; entrance potential (EP), −10; CUR, 10 psi; IS,
−4500V; GS1, 45 psi; GS2, 45 psi; temperature, 400◦C. The
high-purity nitrogen and zero grade air that were used as
the CUR, GS1 and GS2 gases were produced by a high-
purity nitrogen generator from PEAK Scientific Instruments
(Chicago, IL, USA).
2.7. Animals. Male Wistar rats (200–300 g) from the colony
of the Federal University of Goia´s were used in this study. The
animals were housed under a controlled 12 h light/dark cycle
and stable temperature (22-23◦C) with free access to food
and water. All experiments were conducted in accordance
with the Sociedade Brasileira de Cieˆncia em Animais de
Laborato´rio (SBCAL) and were approved by the local Ethics
in Research Committee (Protocol CEP/UFG 22/2011).
2.8. Preparation of Rat Aortic Rings. Rats were anesthetized
and subsequently decapitated with a guillotine. The thoracic
aorta was removed, cleaned of adhering fat and connective
tissue, and then segmented into rings of 4mm in length.
Aortic rings were mounted under 1.5 g resting tension
on stainless steel hooks in 9.0mL warmed (37◦C) and
oxygenated (95% O2 and 5% CO2) organ baths containing
a modified Krebs-Henseleit solution (pH 7.4; composition
in mM: NaCl—130, NaHCO3—14.9, KCl—4.7, KH2PO4—
1.18, MgSO4·7H2O—1.17, CaCl2·2H2O—1.6, glucose—
5.5). The changes in basal tension were recorded by isometric
transducers connected to a data acquisition system (World
Precision Instruments, Sarasota, FL, USA). The aortic rings
were placed under a resting tension of 1.5 g and equilibrated
for 60min. During this period, tension was periodically
adjusted to the desired level and the Krebs-Henseleit solution
was changed every 15min.
2.9. Measurement of Vascular Eﬀects of the CHE and
Its Fractions and Investigation of Mechanisms of Action.
Endothelium-intact aorta rings were precontracted with Phe
(0.1 μM).When the contractile responses to Phe had reached
a plateau (usually after 15min), cumulative concentrations
(0.1 μg/mL to 30 μg/mL) of CHE or organic fractions (HF;
CF; EAF or BF) were added to evaluate the vascular
eﬀects. Extract and fractions solutions were prepared in 5%
DMSO. The vehicle (DMSO) was also tested and the final
concentration in all chambers did not exceed 0.1% (v/v).
The BF, which showed a vasorelaxant eﬀect similar to CHE,
was chosen for the studies of the mechanism of action and
hypotensive eﬀect.
The integrity of the endothelium was tested in each
vessel by observing the relaxation response to ACh (10 μM)
following precontraction with Phe (0.1 μM). In order to
investigate whether BF-induced relaxation was dependent
on the integrity of the vascular endothelium, concentration-
response curves to BF (0.1 μg/mL to 30 μg/mL) were deter-
mined in endothelium-denuded rings precontracted with
Phe. The absence of ACh-induced vasorelaxant eﬀects was
taken as evidence that the arterial rings were eﬀectively
stripped of endothelium. Finally, SNP (1 μM), an NO-donor,
was added to produce endothelium-independent relaxation.
In addition, endothelium-intact aorta rings were incu-
bated with L-NAME (100 μM), a nitric oxide (NO) synthase
inhibitor, for 30min. After the incubation period, aorta
rings were then stimulated with Phe (0.1 μM) or KCl
(120mM). When the contractile response had reached a
plateau, cumulative concentration-eﬀect curves for BF were
constructed.
To investigate the role of prostaglandins and K+ channels
on BF-induced relaxation, concentration-response curves
were constructed in the presence of indomethacin (10 μM)
(a cyclooxygenase (COX) inhibitor) and TEA (1mM) (a
nonselective K+ channel blocker). The involvement of
guanylylcyclase on BF-induced relaxation was measured in
the presence of ODQ (10 μM), a soluble guanylylcyclase
inhibitor.
The involvement of endothelial receptors in the vascular
eﬀects of BF was measured after incubation of atropine
(10 μM), a muscarinic receptor antagonist, or pyrilamine
(10 μM), a histamine H1-receptor antagonist. In each case,
vessels were incubated with inhibitors for 30min prior to
being precontracted with Phe. Responses of the tissues to BF
were directly compared to those obtained in the same tissues
in the absence of the inhibitors (control).
Endothelium-denuded rings were incubated in Ca2+-free
high K+ (60mM) depolarizing Krebs-Henseleit solution. A
cumulative concentration-response curve to CaCl2 (10 μM
to 0.1mM) was established in the presence of either BF or
DMSO for 30min. The results were expressed as percentages
of the maximal response for KCl (120mM) and the curves
were statistically compared. In these experiments, no precip-
itation of calcium was observed at the concentrations used.
To address any residual or nonreversible eﬀect of BF
on contractile or relaxation events, aortic rings (exposed to
cumulative concentrations of BF) were washed and allowed
for another 60min interval, before a new exposure to Phe
(0.1 μM) and ACh (10 μM).
2.10. Evaluation of the Eﬀects of BF on Blood Pressure of
Anaesthetized Rats. On the day of experiments, the rats were
anesthetized with halothane (2-3% halothane in 100% O2)
and catheters were inserted into the right femoral vein and
artery. After the catheter placement, the rats were removed
from the halothane and the anesthesia was maintained
with urethane (1.2 g kg−1·b.wt., i.v.; Sigma-Aldrich Co., St.
Louis, MO, USA). The rats were mounted prone in a
stereotaxic apparatus (David Kopf Instruments) with the bite
bar set at 3.4mm below the interaural line. In experiments
measuring the aortic blood flow (ABF), miniature ultrasonic
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transit-time flow probes (Transonic Systems Inc., Ithaca, NY,
USA) were placed around the aorta. The body temperature
was kept at 37 ± 0.5◦C with a thermostatically controlled
heated table.
To register blood pressure, the arterial catheter was con-
nected to a pressure transducer attached to a bridge amplifier.
The pulsatile pressure was recorded continuously with an
MP150 analog-to-digital converter (Biopac Systems, Inc.,
Goleta, CA, USA). The mean arterial pressure (MAP) was
determined through the pulsate signal with AcqKnowledge
software (version 3.7.1.; Biopac Systems). To measure the
aortic blood flow (ABF), a flow probe was connected to
an ultrasonic transit-time flowmeter (Transonic Systems).
Aortic vascular conductance (AVC) was obtained by the
ratio between ABF and MAP. Either the extract (i.e., BF)
(7.15, 14.3, 28.6, 57.2, 114.4, and 228.8 μg kg−1·b.wt., i.v.; in
0.1mL) or the vehicle (DMSO 5%) was infused through the
femoral vein cannula.
2.11. Statistical Analysis. The results are presented as the
mean ± SEM of 6–8 experiments. Statistical significance was
determined using Student’s t-test or one-way analysis of vari-
ance (ANOVA) followed by Bonferroni’s post hoc test when
appropriate. A P value of <0.05 was considered statistically
significant. Analyses were performed using GraphPad Prism
version 5.00 for Windows (San Diego, CA, USA).
3. Results
3.1. Vascular Eﬀects of the CHE and Its Fractions.
Endothelium-intact aortic rings precontracted with Phe
(0.1 μM) relaxed in a concentration-dependent manner in
response to the cumulative addition of CHE and organic
fractions (HF; CF; EAF or BF). CHE and BF produced
potent and similar relaxations (Emax = 97.4 ± 2.2% and 94.4
± 2.5%, resp.) (Figure 1). The EC50 for CHE and BF was
3.9 μg (2.8–5.4) and 5.6 μg (3.5–8.9), respectively. The EAF,
HF and CF elicited a maximum relaxation of 74.7 ± 3.8%,
59.1 ± 7.1% and 34.7 ± 8.6%, respectively. The vehicle had
no significant relaxant eﬀect (<5%). Sixty minutes after
the extracts were removed from the baths, the eﬀects of
either Phe or ACh were similar to those seen before the
addition of the extracts (data not shown). Because BF was
the organic fraction with the best profile of vasorelaxation,
we established cumulative concentration-response curves
to this fraction in order to investigate the mechanism of
action. Unlike the eﬀect observed in endothelium-intact
aortic rings, the BF-induced relaxation was abolished in
preparations without endothelial cells (Figure 2). We also
found that the endothelium-denuded rings incubating with
depolarizing and nominally without Ca2+ solution, CaCl2
was able to induce contractions that were not inhibited by
BF in doses of 0.3, 3, and 30 μg/mL (Figure 3).
In aortic tissue precontracted with Phe (0.1 μM), incu-
bation with L-NAME (NOS inhibitor) or ODQ (a guanylyl-
cyclase inhibitor) was able to completely inhibit the relax-
ation induced by BF (Figure 4(a)). In intact endothelium
precontracted with KCl (120mM), the BF produced less
relaxation (Emax 63,7 ± 7,0%) compared to that observed
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Figure 1: Cumulative concentration-response curves (0.1 to
30 μg/mL) for crude hydroalcoholic extract (CHE), hexane fraction
(HF), chloroform fraction (CF), ethyl acetate fraction (EAF), and
butanolic fraction (BF) of C. brasiliense leaves in rats aortic rings
with intact endothelium precontracted with phenylephrine (Phe)
(0.1 μM). The results show the mean ± SEM of 6–8 experiments.
∗P < 0.05 when compared to vehicle (DMSO).
with the Phe (Emax 94,4 ± 2,5%). However, the pretreatment
with L-NAME (100 μM) completely inhibited the relaxation
produced by BF in aortic rings precontracted with KCl
(Figure 4(b)). The eﬀects of atropine and pyrilamine are
shown in Figure 5. BF-induced aortic relaxation was not
attenuated after incubation with atropine or pyrilamine,
respectively. Moreover, the incubation of the arteries with
indomethacin (a cyclooxygenase inhibitor) or TEA (a K+
channel blocker) did not change the relaxant eﬀect of BF in
arteries precontracted with Phe (Figure 6).
3.2. Eﬀects of Intravenous Extract Infusion on Cardiovascular
Responses. In anesthetized rats, infusion of the vehicle did
not promote changes in MAP (−2 ± 0.67mmHg of baseline
values; Figure 7(a)), ABF (3.4 ± 0.6% of baseline values;
Figure 7(b)) or AVC (4.6 ± 0.65% of baseline values;
Figure 7(c)). Intravenous infusion of the BF (7.15, 14.3, 28.6,
57.2, 114.4, and 228.8 μg kg−1·b.wt.) produced a significant
dose-dependent hypotension (−5.6± 1.1;−6.9± 0.9;−8.8±
1.2; −9.0 ± 0.9; −13.0 ± 2.6; −21.5 ± 1.6mmHg of baseline
values, respectively, Figure 7(a)), as well as increases in ABF
(6.7 ± 0.8; 7.3 ± 0.7; 8.8 ± 0.5; 8.9 ± 0.8; 13.6 ± 2.5; 16.5 ±
3.8% of baseline values, respectively, Figure 7(b)) and in AVC
(11.0 ± 1.7; 13.4 ± 0.1; 16.1 ± 2.2; 17.9 ± 1.4; 19.7 ± 2.5;
42.0 ± 3.3% of baseline values, resp., Figure 7(c)).
3.3. Analysis of Butanolic Fraction by LC-MS. LC-ESIMS
analysis were carried out exploring the representative ions
of standards of gallic acid and quercetin in order to confirm
the presence or absence of these compounds in butanolic
fraction (BF) from Caryocar brasiliense leaves. Analysis of BF
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Figure 2: Cumulative concentration-response curves (0.1 to
30 μg/mL) for butanolic fraction (BF) of C. brasiliense leaves in rats
aortic rings with intact or denuded endothelium precontracted with
phenylephrine (Phe) (0.1 μM). The results show the mean ± SEM
of 6–8 experiments. ∗P < 0.05 when compared to endothelium-
denuded aortic rings.
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Figure 3: Eﬀect of BF (0.3, 3, and 30 μg/mL) on the contractile
responses elicited by incremental addition of Ca2+ (10 μM–0.1mM)
to aortic rings depolarized by isotonic KCl (60mM) in a Ca2+-
free solution. The concentrations of BF are indicated on the graph.
Contractile responses are expressed as the percentage of maximum
contraction evoked by KCl (120mM). The results show the mean ±
SEM of 5–7 experiments.
in the positive and negative mode were obtained to adjust
the LC-ESIMS conditions. Posteriorly, standards solutions
were injected by LC-ESIMS with the purpose of choosing the
most appropriate ionization mode and concentration for the
analysis of these compounds in fraction. In the mass spectra
extracted from chromatogram in tR = 3.5min and 23.4min
obtained in negative mode experiment of BF was observed
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Figure 4: Cumulative concentration-response curves for butanolic
fraction (BF) in aortic rings with intact endothelium precontracted
with (a) phenylephrine (Phe) (0.1 μM) in the presence of Nω-
nitro-L-arginine methyl ester (L-NAME) (a nitric oxide synthase
inhibitor, 100 μM) or 1H-[1, 2, 4]oxadiazolo [4,3-alpha]quinoxalin-
1-one (ODQ) (a guanylylcyclase inhibitor, 100 μM) and (b) precon-
tracted with KCl (120mM) in the presence or absence of L-NAME
(100 μM). The results show the mean ± SEM of 6–8 experiments.
∗P < 0.05 when to control (Phe or KCl).
the quasimoleculares ions [M − H]− at m/z 169.0 and m/z
301.3, concordant with observed for gallic acid and quercetin
standards, respectively. In addition, there were also observed
characteristics fragments ions at m/z 125.2 and m/z 150.8,
obtained by dissociation of quasimoleculares ions [M −H]−
of gallic acid and quercetin compounds, respectively, in ESI
source (Figures 8 and 9). The quercetin compound was also
confirmed in positive mode experiment, which was observed
the presence of quasimolecular ion [M + H]+ at m/z 303.0.
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Figure 5: Relaxation evoked by BF before (control curve) and
after exposure to pyrilamine (a H1 receptor antagonist; 10 μM) or
atropine (a muscarinic antagonist receptor; 10 μM) in rat aortic
rings. The results are expressed as mean± SEM of 5–7 experiments.
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Figure 6: Relaxation evoked by BF in the absence (control curve) or
presence of tetraethylammonium (TEA, a nonselective potassium
channel blocker; 1mM) and indomethacin (a cyclooxygenase
inhibitor; 10 μM) in rat aortic rings. The results are expressed as
mean ± SEM of 6-7 experiments.
4. Discussion
The observation that the butanolic fraction of leaves of C.
brasiliense is able to fully relax rat aortic rings and dose-
dependently reduce the blood pressure of anaesthetized rats
is themain finding of this study. In the first stage of this study,
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Figure 7: Eﬀects of BF infusion (7.15, 14.3, 28.6, 57.2, 114.4,
and 228.8 μg kg−1·b.wt., i.v.; in 0.1mL) on the cardiovascular
parameters in anesthetized rats. (a) Mean arterial pressure (MAP).
(b) Aortic blood flow (ABF). (c) Aortic vascular conduction (AVC).
The results are expressed as mean ± SEM of 6–9 experiments ∗P <
0.05 when compared to vehicle (DMSO).
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Figure 8: LC-ESIMS analysis of butanolic fraction (BF) from of
C. brasiliense leaves. (a) Chromatogram of BF in methanol/water
solution (70 : 30, v/v) with 1mM ammonium formate. (b) Mass
spectra extracted in tR = 3.5min of chromatogram of BF. (c) Mass
spectra extracted in tR = 23.4min of chromatogram of BF.
we showed that the crude hydroalcoholic extract (CHE) of
C. brasiliense leaves was able to fully relax rat aortic rings.
In the second stage, we found that the BF obtained from
CHE showed better vasorelaxation compared to that of other
organic fractions (i.e., HF, CF, and EAF) and that it was
similar to the eﬀect induced by CHE. Subsequently, the
investigation of themechanism of action and the hypotensive
eﬀect was performed with the BF. After the experiments
on aortic rings with or without endothelium, we observed
that the vasorelaxation eﬀect of BF was dependent on
endothelium, since the endothelium-denuded aortic ring
preparations were not able to relax after the addition of BF.
When we constructed a concentration-response curve to
CaCl2 in a high K+ solution before and after incubation with
BF, it was not capable of antagonizing the CaCl2-induced
contractions, suggesting that the BF is not acting as a calcium
channel blocker. This result confirms the absence of eﬀect on
smooth muscle cells.
The vascular endothelium plays an important role in
cardiovascular functions, mainly by controlling arterial tone
via synthesis and release of potent vasodilators such as
nitric oxide, vasodilator prostaglandins (e.g., prostacyclin)
and endothelium-derived hyperpolarizing factor (EDHF)
[16]. Accordingly, to verify the involvement of endothelium-
derived vasodilators, the eﬀect of L-NAME on the BF-
induced vasorelaxation was investigated. We demonstrated
that NO is involved in the BE-induced vasorelaxation of
aortic rings with intact endothelium because L-NAME (a
nitric oxide synthase inhibitor) as well as ODQ (a soluble
guanylatecyclase inhibitor) abolished this eﬀect. The finding
that BF produced greater relaxation of Phe-contracted
aortic rings than KCl-contracted aortic rings (Figure 4)
is also consistent with the properties of NO-dependent
vasorelaxation [17–19]. It is unlikely that prostacyclin and
potassium channels are involved in this eﬀect because
indomethacin and TEA (a prostaglandins inhibitor and a
potassium channels blocker, resp.) were not able to reduce
the vasodilatation eﬀect induced by BF.
We also investigated the possible mechanism involved in
the ability of BF to stimulate NO release. Under physiological
conditions, NO is continuously released by endothelial cells
as a consequence of the shear stress generated by blood flow.
However, its release is also mediated by the activation of
muscarinic [17] and histaminic H1 [20] receptors, among
others. Our results indicate that neither cholinergic nor
histaminergic pathways are involved, since the vasorelaxation
eﬀect induced by BF was unchanged by incubation with
atropine and pyrilamine, respectively.
Consistent with vascular reactivity results, the infusion of
BF in anesthetized rats induced an increase of AVC, indicat-
ing aortic vasodilation. In addition, this aortic vasodilation
may be related, at least partly, to the hypotensive eﬀect
induced by BF.
The exposure of BF did not result in any long-lasting
impairment in the contractile or relaxation functions of
the aortic rings, and was found to cause a reversible
hypotension in rats. This suggests that, at least in the range of
concentrations and doses used in this study, this extract does
not have deleterious eﬀects.
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Figure 9: LC-ESIMS analysis of gallic acid and quercetin standards in methanol/water solution (70 : 30, v/v) with 1mM ammonium
formate. (a) Chromatogram of gallic acid standard. (b) Chromatogram of quercetin standard. (c) Mass spectra extracted in tR = 23.5min of
chromatogram of gallic acid standard. (d) Mass spectra extracted in tR = 3.7min of chromatogram of quercetin standard.
In this study, the butanolic fraction of C. brasiliense
leaves presented a better profile for aortic ring relaxation
compared to that of the other organic fractions. Butanol is a
solvent of higher polarity and it extracts flavonoids, tannins,
and saponins, among others chemical substances [21]. In a
previous study, the chemical characterization of the polar
components of pequi fruits showed the presence of bioactive
components such as gallic acid and quercetin [9]. Similarly,
the LC-ESIMS analysis showed the presence of gallic acid and
quercetin in BF. The methods applied are simple and direct
for rapid identification of phenolic compounds in plant
fraction of C. brasiliense. It eliminated tedious procedures of
separation and purification, providing suﬃcient information
to the confirmation of known compounds when standards
mass spectra and fragmentation profile are compared to
literature.
It has been described that quercetin is eﬀective for
enhancing the bioavailability of endothelium-derived nitric
oxide [22, 23], while gallic acid is known to induce vascular
relaxation in higher concentrations [24]. Accordingly, the
confirmation of presence of gallic acid and quercetin in BF
by LC-MS can help in the understanding of its vasorelaxant
eﬀect, since these compounds have been reported in the
literature for such activity.
5. Conclusions
Our results reveal that C. brasiliense possesses both in vivo
and in vitro activities and that the vascular eﬀect of BF
involves stimulation of the nitric oxide/cyclic GMP pathway.
In addition, these findings corroborate previous work per-
formed with volunteer athletes, which demonstrated that the
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administration of pequi caused hypotension. So, this work
contribute to our understanding of the potential use of C.
brasiliense in pathological conditions, such as hypertension
and atherosclerosis.
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